BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29580104)

  • 1. Soluble glycoprotein 130 is inversely related to severity of coronary atherosclerosis.
    Korotaeva AA; Samoilova EV; Chepurnova DA; Zhitareva IV; Shuvalova YA; Prokazova NV
    Biomarkers; 2018 Sep; 23(6):527-532. PubMed ID: 29580104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IL-6-neutralizing sIL-6R-sgp130 buffer system is disturbed in patients with type 2 diabetes.
    Aparicio-Siegmund S; Garbers Y; Flynn CM; Waetzig GH; Gouni-Berthold I; Krone W; Berthold HK; Laudes M; Rose-John S; Garbers C
    Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E411-E420. PubMed ID: 31237452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating interleukin 6 and soluble forms of its receptors in relation to resting energy expenditure in women with anorexia nervosa.
    Karczewska-Kupczewska M; Adamska A; Nikołajuk A; Otziomek E; Górska M; Kowalska I; Strączkowski M
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):812-6. PubMed ID: 23199226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels.
    Wonnerth A; Katsaros KM; Krychtiuk KA; Speidl WS; Kaun C; Thaler K; Huber K; Wojta J; Maurer G; Seljeflot I; Arnesen H; Weiss TW
    Metabolism; 2014 May; 63(5):647-53. PubMed ID: 24629561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased levels of IL-6, sIL-6R, and sgp130 in the aqueous humor and serum of patients with diabetic retinopathy.
    Chen H; Zhang X; Liao N; Wen F
    Mol Vis; 2016; 22():1005-14. PubMed ID: 27563232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of sgp130 and sex hormones in male patients with coronary atherosclerotic disease.
    Cui Y; Dai W; Li Y
    Atherosclerosis; 2017 Nov; 266():151-157. PubMed ID: 29028483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.
    Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J
    J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness.
    Weiss TW; Arnesen H; Seljeflot I
    Metabolism; 2013 Jul; 62(7):1008-13. PubMed ID: 23428306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6 and its receptors in coronary artery disease and acute myocardial infarction.
    Anderson DR; Poterucha JT; Mikuls TR; Duryee MJ; Garvin RP; Klassen LW; Shurmur SW; Thiele GM
    Cytokine; 2013 Jun; 62(3):395-400. PubMed ID: 23582716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis.
    Oelzner P; Franke S; Lehmann G; Eidner T; Hein G; Wolf G
    Rheumatol Int; 2012 Jan; 32(1):199-206. PubMed ID: 20821212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary sinus concentrations of interleukin 6 and its soluble receptors are affected by reperfusion and may portend complications in patients with myocardial infarction.
    Kaminski KA; Kozuch M; Bonda T; Wojtkowska I; Kozieradzka A; Dobrzycki S; Kralisz P; Nowak K; Prokopczuk P; Winnicka MM; Musial WJ
    Atherosclerosis; 2009 Oct; 206(2):581-7. PubMed ID: 19406401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.
    Robak T; Wierzbowska A; Błasińska-Morawiec M; Korycka A; Błoński JZ
    Mediators Inflamm; 1999; 8(6):277-86. PubMed ID: 10815616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of interleukin-6 and its soluble receptors by activated peripheral blood monocytes is elevated in hypocholesterolemic hemodialysis patients.
    Tsirpanlis G; Chatzipanagiotou S; Boufidou F; Kordinas V; Alevyzaki F; Zoga M; Kyritsis I; Ioannou D; Fatourou A; Nicolaou C
    Am J Nephrol; 2005; 25(5):484-90. PubMed ID: 16127269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurements of IL-6, soluble IL-6 receptor and soluble gp130 in sera of B-cell lymphoma patients. Does viscum album treatment affect these parameters?
    Kovacs E; Kuehn JJ
    Biomed Pharmacother; 2002 May; 56(3):152-8. PubMed ID: 12046687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) and soluble gp130 (sgp130) in sera of cancer patients.
    Kovacs E
    Biomed Pharmacother; 2001 Sep; 55(7):391-6. PubMed ID: 11669502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility.
    Sherwin JR; Smith SK; Wilson A; Sharkey AM
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3953-60. PubMed ID: 12161539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of serum soluble interleukin-6 receptor and soluble gp130 levels in patient with pregnancy induced hypertension and its significance].
    Li Y; Wang Y; Qi L
    Zhonghua Fu Chan Ke Za Zhi; 2001 Jan; 36(1):18-9. PubMed ID: 11778537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced IL-6 trans-signaling in pulmonary arterial hypertension and its potential role in disease-related systemic damage.
    Jasiewicz M; Knapp M; Waszkiewicz E; Ptaszynska-Kopczynska K; Szpakowicz A; Sobkowicz B; Musial WJ; Kaminski KA
    Cytokine; 2015 Dec; 76(2):187-192. PubMed ID: 26163998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases.
    Nikolaus S; Waetzig GH; Butzin S; Ziolkiewicz M; Al-Massad N; Thieme F; Lövgren U; Rasmussen BB; Reinheimer TM; Seegert D; Rosenstiel P; Szymczak S; Schreiber S
    Int J Colorectal Dis; 2018 Jul; 33(7):927-936. PubMed ID: 29748708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
    Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
    J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.